Abiopharma

The Wizard of Oz at Sphere Celebrates One Year of Redefining Immersive Storytelling

Mortgage Rates Average 6.69%

Bronstein, Gewirtz & Grossman LLC Urges Avis Budget Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

LECTRA : Déclaration mensuelle du nombre total dactions et de droits de vote composant le capital social (au 31 juillet 2026)

LECTRA: Monthly declaration of the total number of shares and voting rights composing the companys capital (at July 31st, 2026)

Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Georgia Power Generation employees keep reliable energy flowing throughout the hottest days of summer

SEI Launches ANGU ETF, Bringing Factor Research to Traditional Index Exposure

Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company

Theriva™ Biologics anuncia que se ha administrado la primera dosis a un paciente en el ensayo clínico VIRAGE2 de Fase IIa, destinado a evaluar una administración más frecuente de VCN-01 (zabilugene almadenorepvec) en pacientes en tratamiento de primera línea con adenocarcinoma ductal pancreático metastásico

Chemed Corporation Declares Quarterly Dividend of 70 Cents

Dogfish Head to Host Dog & Owner Lookalike Contest this National Dog Day

KLÉPIERRE RELEASES ITS FIRST-HALF 2026 FINANCIAL REPORT

MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2026